病理學科

Medicine & Life Sciences

1. Neoplasms 100%
2. Neoplasm Metastasis 65%
3. Prostatic Neoplasms 57%
4. Taiwan 39%
5. Carcinoma 36%
6. Skin 33%
7. Nasopharyngeal Carcinoma 31%
8. Breast Neoplasms 29%
9. Neoplastic Stem Cells 28%
10. Human Herpesvirus 4 27%
11. Hepatocellular Carcinoma 26%
12. Growth 26%
13. Colorectal Neoplasms 25%
14. Stomach Neoplasms 25%
15. Bone and Bones 24%
16. Therapeutics 24%
17. Epithelial-Mesenchymal Transition 22%
18. Down-Regulation 22%
19. Stomach 21%
20. Toxocara canis 21%
21. Recurrence 20%
22. Survival 20%
23. MicroRNAs 20%
24. Lymph Nodes 19%
25. ErbB Receptors 19%
26. Pharmaceutical Preparations 19%
27. Proteins 18%
28. In Vitro Techniques 18%
29. Breast 16%
30. Androgens 16%
31. Colonic Neoplasms 16%
32. Cell Proliferation 16%
33. Drug Therapy 16%
34. Biomarkers 16%
35. Carcinogenesis 16%
36. Catenins 15%
37. Staining and Labeling 15%
38. Magnetic Resonance Imaging 15%
39. Heterografts 14%
40. Cell Line 14%
41. Squamous Cell Carcinoma 14%
42. Biopsy 14%
43. Protein-Tyrosine Kinases 14%
44. Skin Absorption 14%
45. Bone Neoplasms 14%
46. Triple Negative Breast Neoplasms 13%
47. Lung Neoplasms 13%
48. glucose-regulated proteins 13%
49. Helicobacter pylori 13%
50. Sarcoma 13%
51. 4-acetylantroquinonol B 12%
52. Up-Regulation 12%
53. Glioblastoma 12%
54. Prostate 12%
55. pterostilbene 12%
56. Solid-State Lasers 12%
57. Glioma 12%
58. Phenotype 12%
59. Genes 12%
60. Liver 12%
61. Cell Movement 12%
62. Androgen Receptors 12%
63. Marginal Zone B-Cell Lymphoma 12%
64. Adenocarcinoma 12%
65. Epstein-Barr virus EBV-associated membrane antigen 11%
66. Lymphoma 11%
67. Castration 11%
68. Squamous Cell Carcinoma of Head and Neck 11%
69. Cisplatin 11%
70. Transforming Growth Factors 11%
71. Messenger RNA 10%
72. Ovarian Neoplasms 10%
73. Epidermal Growth Factor 10%
74. hydroquinone 10%
75. Adenocarcinoma of Lung 10%
76. Nude Mice 10%
77. Lung 10%
78. Neck 10%
79. Membrane Proteins 10%
80. Immunohistochemistry 10%
81. Disease-Free Survival 9%
82. Magnetic Resonance Spectroscopy 9%
83. Nitric Oxide Synthase Type II 9%
84. osteoblast cadherin 9%
85. Mutation 9%
86. Renal Cell Carcinoma 9%
87. Brain 9%
88. T-Cell Lymphoma 9%
89. Pylorus 9%
90. Radiotherapy 9%
91. Histology 9%
92. Bariatric Surgery 8%
93. Phosphotransferases 8%
94. Erbium 8%
95. Toxocariasis 8%
96. Apoptosis 8%
97. Cell Cycle 8%
98. Phosphorylation 8%
99. Collagen 8%
100. Peripheral T-Cell Lymphoma 8%